Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Decreases By 42.6%

Coloplast A/S (OTCMKTS:CLPBY) was the target of a large drop in short interest during the month of February. As of February 15th, there was short interest totalling 60,700 shares, a drop of 42.6% from the January 31st total of 105,800 shares. Based on an average trading volume of 242,400 shares, the short-interest ratio is currently 0.3 days.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Hsbc Global Res raised shares of Coloplast A/S from a “moderate sell” rating to a “hold” rating in a research note on Monday, November 18th. Sanford C. Bernstein upgraded Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, UBS Group upgraded Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th.

Coloplast A/S Trading Down 1.3 %

OTCMKTS CLPBY traded down $0.14 during trading on Friday, hitting $10.60. The company had a trading volume of 172,314 shares, compared to its average volume of 189,949. The company’s fifty day moving average is $11.11 and its 200-day moving average is $12.32. Coloplast A/S has a one year low of $10.54 and a one year high of $14.34. The company has a quick ratio of 0.66, a current ratio of 1.02 and a debt-to-equity ratio of 0.92.

Coloplast A/S (OTCMKTS:CLPBY) last released its quarterly earnings results on Tuesday, February 4th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. Equities research analysts expect that Coloplast A/S will post 0.31 earnings per share for the current year.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.